Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cisadane Sawit Raya Tbk (CSRA) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

Cisadane Sawit Raya TbkTrade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

Cisadane Sawit Raya Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Cisadane Sawit Raya Tbk trades at Rp740 (market cap 1.53T, 23.6K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume). The key difference: Cisadane Sawit Raya Tbk is far larger — about 4.8× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (41.7K versus 23.6K). Which is the better fit depends on your goals.

CSRADGNS
Market Cap
1.53T316.25B
Volume
23.6K41.7K
Lot
236417
Turnover
17.42M9.66M
Average Price
738.11231.65
Value
17.42M9.66M
Indicative Equilibrium Price
740230
Indicative Equilibrium Volume
102.4K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CSRA
View details
DGNS
View details

About Cisadane Sawit Raya Tbk

PT Cisadane Sawit Raya Tbk (the Company) was established based on Notarial Deed No. 82 dated October 28, 1983 of Public Notary Erly Soehandjojo, S.H., amended by Notarial Deed No. 107 dated November 25, 1987 of Public Notary H.Z. Simon, S.H.

Read more on CSRA

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS